Lumida
/CORT
⌘K
Corcept Therapeutics Inc

Corcept Therapeutics Inc

CORT
$112.79USD-1.85%-2.13 today

MARKET CAP

12.2B

P/E (TTM)

322.3x

FWD P/E

DAY RANGE

$109 – $118

52W RANGE

$29
$126

AI Summary

Stalk
Sell NowMedium

Following activation of a Bearish Pivot Point and break below the 9- and 20-day EMAs, CORT exhibits a medium-term bearish bias under a Stage 4 decline. Short-term price shows rejection at these EMAs and the 50-day SMA acting as resistance, with no signs of stabilization or exhaustion. Immediate sell-side engagement into this resistance zone is advised, while a sustained close above the EMAs would invalidate the downside bias.

  • Q2 2026 revenue +32% YoY to $256.1M; raised 2025 guidance to $800M–$850M
  • Korlym sales and LIFYORLI launch boost prescriptions +42.5% YoY
  • Net income plunged to $19.7M from $47.2M YoY amid higher expenses
Full analysis →

Buying

7

institutions

Selling

9

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY12.43 M1.08 B+280.75 K+120.7%0.02%
RT

Renaissance Technologies LLC

Q2 2026

SELL5.26 M457.50 M+-421.15 K+99.7%0.63%
AC

Aqr Capital Management LLC

Q2 2026

BUY2.58 M224.55 M+2.18 M+1314.6%0.08%
CA

Citadel Advisors LLC

Q2 2026

SELL425.70 K37.02 M+-118.92 K+68.6%0.00%
PA

Perceptive Advisors LLC

Q2 2026

BUY398.38 K34.64 M+298.38 K+759.3%0.52%
JC

Jpmorgan Chase & Co

Q2 2026

BUY253.18 K22.65 M+52.23 K+195.7%0.00%
MM

Millennium Management LLC

Q2 2026

SELL216.17 K18.80 M+-342.58 K-16.6%0.01%
JH

Janus Henderson Group Plc

Q1 2026

BUY328.15 K13.23 M+174.89 K+148.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL123.39 K10.73 M+-109.00+115.5%0.02%
MG

Man Group Plc

Q2 2026

SELL71.49 K6.22 M+-6.11 K+98.7%0.01%
BA

Bridgewater Associates, LP

Q2 2026

BUY57.60 K5.01 M+19.18 K+223.4%0.02%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW25.35 K2.20 M+25.35 K+0.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL10.10 K878.20 K+-46.08 K-61.2%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

SELL0.000.00+-126.00 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-8.02 K-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-8.00 K-100.0%0.00%